FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely to an agent for treating arthrological diseases. Disclosed is an agent for treating arthrological diseases containing an effective amount of chondroitin sodium sulphate and at least one auxiliary substance and/or carrier, which additionally contains copper in a relative amount of 1 mg/kg to 20 mg/kg in terms of the weight of the active substance – sodium chondroitin sulphate.
EFFECT: use of the invention enables to significantly reduce the therapeutic course by increasing the therapeutic efficacy of sodium chondroitin sulphate in the composition with copper in the above amount.
1 cl, 25 tbl, 2 ex
Authors
Dates
2025-02-25—Published
2024-12-03—Filed